📰 Newspapers

China fires researchers after child dies in gene-editing trial

China fires researchers after child dies in gene-editing trial

Investigators found scientists failed to flag warning signals from a non-human-primate safety and didn’t disclose the child’s death in the research paper.

Chinese authorities fired two researchers and disciplined several others after an investigation found safety and ethical flaws in an experimental gene-editing study that led to the death of a child.

The two key researchers leading the study at Shanghai Jiao Tong University School of Medicine also were barred for five years from government science and technology projects, state media China Central Television reported on Nov 13.

Several others received penalties, including removal from their posts, demotions and disciplinary warnings, according to the CCTV report that cited a Shanghai investigative task force.

Investigators found scientists failed to flag warning signals from a non-human-primate safety and didn’t disclose the child’s death in a research paper published in February, CCTV said.

No data fabrication was found, though other academic irregularities and undisclosed conflicts of interest were identified.

The hospital’s ethics committee approved the study despite insufficient toxicology and safety evidence, and the risk of death wasn’t highlighted in the informed consent disclosures.

Shanghai authorities said they will strengthen oversight of clinical research involving new biomedical technologies, including high-risk cell and gene therapies, according to the report.

The city’s health commission has drawn up a special inspection plan and begun inspections and rectification work, it added.

The child’s death, first reported in late July by Science and Retraction Watch, drew scrutiny of China’s booming…

In brief

Chinese authorities fired two researchers and disciplined several others after an investigation found safety and ethical flaws in an experimental gene-editing study that led to the death of a child. Shanghai authorities said they will strengthen oversight of clinical research involving new biomedical technologies, including high-risk cell and gene therapies, according to the report. The child’s death, first reported in late July by Science and Retraction Watch, drew scrutiny of China’s booming…

This is the opening of the story, shared with credit to The Straits Times — Asia. The rest of the report — with every detail — continues on the publisher’s website.

Continue reading at The Straits Times — Asia ↗

Cookie settings

Choose which cookies we may use. You can change this at any time from Cookie settings in the footer. Details of each cookie are in the Cookie Policy.

Strictly necessary

Needed for sign-in, security, payments and remembering these choices. Always on.

Preferences

Remember settings such as dark mode.

Analytics & performance

Help us count visits, understand which pages, devices and countries our readers use, and measure how well the site performs – anonymous and aggregated.

Advertising & marketing

Lets advertising partners show and personalise adverts, measure impressions, clicks and visits, prevent ad fraud and pay us – this is how the free site is funded.

🔔 News notifications

Get headlines from NewsHub on this device — even when the site is closed.

You can switch this off at any time. Works on Android, Windows, Mac and Linux browsers; on iPhone/iPad add the site to your Home Screen first.